103733-30-8

Basic information

• Product Name: CarboxylicAcidPhenylMethylEsterHydrochloride,QuinaprilHcl
• Synonyms: CarboxylicAcidPhenylMethylEsterHydrochloride,QuinaprilHcl;(S)-1,2,3,4-Tetra hydro-3-Isoquinoline carboxylic acid phenyl methylester hydrochloride;3-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-, phenylMethyl ester, hydrochloride, (3S)-;L-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID BENZYL ESTER HCL;(S)-Benzyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride;Quinapril Bicyclic Acid Benzyl Ester;(S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid benzyl ester HCl
• CAS NO: 103733-30-8
• Molecular Formula: C₁₇H₁₇NO₂*ClH
• Molecular Weight: 647.5859
• Mol File: 103733-30-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 411.6°Cat760mmHg
• Flash Point: 202.8°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 5.5E-07mmHg at 25°C
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: CarboxylicAcidPhenylMethylEsterHydrochloride,QuinaprilHcl(CAS DataBase Reference)
• NIST Chemistry Reference: CarboxylicAcidPhenylMethylEsterHydrochloride,QuinaprilHcl(103733-30-8)
• EPA Substance Registry System: CarboxylicAcidPhenylMethylEsterHydrochloride,QuinaprilHcl(103733-30-8)

Safety Data

• Hazardous Substances Data: 103733-30-8(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

Quinapril intermediate.

InChI:InChI=1/C17H17NO2.ClH/c19-17(20-12-13-6-2-1-3-7-13)16-10-14-8-4-5-9-15(14)11-18-16;/h1-9,16,18H,10-12H2;1H/t16-;/m0./s1

Upstream product

• 100-39-0 benzyl bromide 
• 115962-35-1 (3S)-2-tert-butoxycarbonyl-1,2,3,4-tetrahydroisoquinole-3-carboxylic acid 

Downstream Products

• 137380-76-8 Boc-D-Trp(CHO)-Tic-OBzl 
• 202860-55-7 (S)-2-[(2S,3S)-2-tert-Butoxycarbonylamino-3-(4-hydroxy-2,6-dimethyl-phenyl)-butyryl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid benzyl ester 
• 82586-54-7 quinapril benzyl ester 
• 82586-55-8 quinapril hydrochloride 

Relevant articles and documents

The stereochemical requirements of the novel δ-opioid selective dipeptide antagonist TMT-Tic

Five conformationally constrained dipeptide TMT-L-Tic analogues have been synthesized and evaluated for their bioactivity using in vitro bioassays. The most potent and selective analogue (2S,3R)-TMT-L-Tic showed 9 nM binding affinity and 4000-fold selectivity for the δ vs μ opioid receptor. The lowest-energy conformation of (2S,3R)-TMT-L-Tic is suggested to be bioactive one in which the X, torsional angle is trans for TMT and gauche (+) for Tic.